Intrinsic Value of S&P & Nasdaq Contact Us

Cryo-Cell International, Inc. CCEL NYSE

NYSE • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Score
41/100
1/7 Pass
SharesGrow Intrinsic Value
$10.44
+184.5%
Analyst Price Target
$8.50
+131.6%

Stock Statistics — CCEL

Cryo-Cell International, Inc. (CCEL) has a market capitalization of $29.56M and trades at $3.67. The 52-week range is 2.72-6.37.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -12.2, Earnings Per Share (EPS) of $-0.30, annual revenue of $31.57M.

The stock has a beta of 0.63, a last dividend of $0.1500, operates in the Healthcare sector.

Trading Data
Current Price$3.67
52-Week Range2.72-6.37
Volume28.7K
Avg Volume (30D)13.22K
Market Cap$29.56M
Beta (1Y)0.63
Last Dividend$0.1500
Company
IPO Date1994-04-04
Employees82
CEODavid I. Portnoy
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS2288951088
CUSIP228895108
Income (Latest Year)
Revenue$31.57M
Gross Profit$24.19M
EBITDA$480.58K
Operating Income$482.39K
Net Income$-2.43M
EPS$-0.30
EPS Diluted$-0.30
Shares Outstanding$8.07M
Balance Sheet (Latest Year)
Total Assets$61.73M
Current Assets$11.76M
Cash & ST Investments$3.3M
Total Liabilities$80.33M
Total Debt$3.2M
Net Debt$2.89M
Total Equity$-18.61M
Debt / Equity-0.17
Valuation Ratios
P/E Ratio-12.2
P/S Ratio0.94
EV/EBITDA (approx)61.5
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message